Fuel Cell Market Set to Reach $18.16 Billion by 2030 Globally, at a CAGR of 26.3%, says…
Delray Beach, FL, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global Fuel Cell Market size is projected to reach USD 18.16 billion by…
Automotive aftermarket projected to reach USD 594.3 billion by 2033 driven by aging vehicle fleets…
Substantial volume of vehicle parc all over the globe, especially in U.S., China and other markets has bolster the automotive…
Case Study: How Competitive Intelligence Supported a FinTech Company in Benchmarking Competitor…
Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- FinTech companies operate in an increasingly competitive environment marked by rapid…
Growing Demand for Custom Research and Surveys as Organizations Seek Deeper Market and Customer…
Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- As business environments become more complex and customer expectations continue to…
Blood Clot Retrieval Devices Market to Reach US$ 5.68 Billion by 2033 as First-Pass Reperfusion…
Growth is anchored by the increasing adoption of mechanical thrombectomy as a standard of care, a heightened clinical focus on…
Benign Prostatic Hyperplasia Surgical Treatment Market to Reach Over US$ 16.5 Billion by 2033 Driven…
Driven by a growing patient population, rapid adoption of minimally invasive and robotic technologies, increased use of…
Ureteral Stents Market to Reach Over US$ 685.05 Million by 2033 Driven by Rising Outpatient Urology…
Growth is fueled by rising procedural volumes, particularly in outpatient settings such as urology-focused Ambulatory Surgical…
Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading…
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease marked by irreversible fibrosis and poor prognosis.…
Ambulatory Surgical Centers Market to Reach Over US$ 142.6 Billion by 2033 Driven by Rising…
This growth is driven by rising surgical volumes, favorable reimbursement frameworks, expanding CMS-approved procedures,…
Idiopathic Pulmonary Fibrosis Market Poised to Reach US$ 6,736.49 Million by 2035 as Late-Stage…
Idiopathic pulmonary fibrosis represents a high need specialty market, with global IPF drug sales of roughly USD 3 billion and…